- Home
- WST vs ARE Comparison
WST vs ARE Comparison
Compare WST & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- ARE
- Stock Information
- Founded
- WST 1923
- ARE 1994
- Country
- WST United States
- ARE United States
- Employees
- WST N/A
- ARE N/A
- Industry
- WST Medical/Dental Instruments
- ARE Real Estate Investment Trusts
- Sector
- WST Health Care
- ARE Real Estate
- Exchange
- WST Nasdaq
- ARE Nasdaq
- Market Cap
- WST 23.2B
- ARE 19.3B
- IPO Year
- WST N/A
- ARE 1997
- Fundamental
- Price
- WST $332.02
- ARE $99.47
- Analyst Decision
- WST Strong Buy
- ARE Buy
- Analyst Count
- WST 5
- ARE 11
- Target Price
- WST $437.75
- ARE $127.36
- AVG Volume (30 Days)
- WST 494.1K
- ARE 1.4M
- Earning Date
- WST 02-13-2025
- ARE 01-27-2025
- Dividend Yield
- WST 0.25%
- ARE 5.31%
- EPS Growth
- WST N/A
- ARE 18.05
- EPS
- WST 6.74
- ARE 1.64
- Revenue
- WST $2,876,400,000.00
- ARE $3,085,452,000.00
- Revenue This Year
- WST N/A
- ARE N/A
- Revenue Next Year
- WST $6.08
- ARE $0.13
- P/E Ratio
- WST $49.37
- ARE $60.46
- Revenue Growth
- WST N/A
- ARE 10.21
- 52 Week Low
- WST $265.00
- ARE $97.14
- 52 Week High
- WST $413.70
- ARE $131.36
- Technical
- Relative Strength Index (RSI)
- WST 58.00
- ARE 36.18
- Support Level
- WST $325.33
- ARE $97.14
- Resistance Level
- WST $335.53
- ARE $99.48
- Average True Range (ATR)
- WST 7.96
- ARE 2.39
- MACD
- WST 0.32
- ARE -0.15
- Stochastic Oscillator
- WST 78.28
- ARE 23.18
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.